Zhengye Biotechnology Holding (ZYBT) Current Assets (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Current Assets for 2 consecutive years, with $24.7 million as the latest value for Q4 2024.
- Quarterly Current Assets fell 5.95% to $24.7 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $24.7 million through Dec 2024, down 5.95% year-over-year, with the annual reading at $24.3 million for FY2024, 9.15% down from the prior year.
- Current Assets for Q4 2024 was $24.7 million at Zhengye Biotechnology Holding, down from $26.3 million in the prior quarter.
- The five-year high for Current Assets was $26.3 million in Q4 2023, with the low at $24.7 million in Q4 2024.